Tecentriq (atezolizumab)

• Non-small cell lung cancer (NSCLC) after surgery: adults with stage II to IIIA NSCLC whose tumors test positive for PD-L1, used alone after surgery and platinum chemotherapy.
• Metastatic NSCLC, first treatment: adults with NSCLC that has spread and has no EGFR or ALK gene changes: used alone when tumors have high PD-L1, or with other cancer medicines for non-squamous NSCLC.
• Metastatic NSCLC after chemotherapy: adults with NSCLC that has spread and grew during or after platinum chemotherapy (and after an FDA-approved targeted medicine if the tumor has EGFR or ALK changes).
• Extensive-stage small cell lung cancer: adults, as a first treatment with carboplatin and etoposide, and as maintenance with lurbinectedin if the cancer has not grown after that first treatment.
• Liver cancer (hepatocellular carcinoma): adults with liver cancer that cannot be removed by surgery or has spread, who have not had earlier medicine treatment for it, used with bevacizumab.
• Melanoma with a BRAF V600 change: adults with melanoma (a skin cancer) that cannot be removed by surgery or has spread and has a BRAF V600 gene change, used with cobimetinib and vemurafenib.
• Alveolar soft part sarcoma: adults and children 2 years and older (IV Tecentriq) with this rare soft-tissue cancer when it cannot be removed by surgery or has spread. Tecentriq Hybreza (under the skin) is for adults and children 12 and older who weigh at least 40 kg (88 pounds)..
• Muscle-invasive bladder cancer: adults, used alone after bladder removal surgery (cystectomy), when a blood test finds tumor DNA left in the body (ctDNA molecular residual disease).
• Colon cancer with mismatch repair deficiency (dMMR): adults and children 2 years and older (IV Tecentriq) with stage III dMMR colon cancer, used after surgery with fluoropyrimidine and oxaliplatin chemotherapy. Tecentriq Hybreza (under the skin) is for adults and children 12 and older who weigh at least 40 kg (88 pounds)..

A prescription is required. Your prescriber decides whether Tecentriq is right for you.

IV infusion, given by a healthcare professional. When your prescriber agrees it can be given at home, we send a skilled nurse from an accredited nursing agency to give it.

Injection under the skin, given by a healthcare professional. When your prescriber agrees it can be given at home, we send a skilled nurse from an accredited nursing agency to give it.

Before the first dose, your prescriber may ask for:

• tests on the tumor or blood for some cancers, such as PD-L1, BRAF V600, ctDNA or dMMR testing
• blood tests of liver function, kidney function (creatinine) and thyroid function
• a pregnancy check for women who can become pregnant

Read the Medication Guide and the full Tecentriq prescribing information, and ask your prescriber or our pharmacists about side effects. Our pharmacists are on call 24 hours a day.

Health plans often require prior authorization for Tecentriq. Our intake team checks your coverage and works with your prescriber’s office on the paperwork before your first delivery.

The manufacturer runs a support program, Genentech Patient Support Services, that may help eligible patients with costs and access.

Offices can call (844) 671-2600 or fax a referral to (844) 671-2601. Use the Oncology Referral Form (PDF).

The manufacturer also publishes Tecentriq Access Solutions prescriber service form and patient consent form.